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Abstract
Background: Mycobacterium avium subsp. paratuberculosis (MAP) causes chronic enteritis in a wide range of animal species.
In cattle, MAP causes a chronic disease called Johne’s disease, or paratuberculosis, that is not treatable and the efficacy of
vaccine control is controversial. The clinical phase of the disease is characterised by diarrhoea, weight loss, drop in milk
production and eventually death. Susceptibility to MAP infection is heritable with heritability estimates ranging from 0.06 to
0.10. There have been several studies over the last few years that have identified genetic loci putatively associated with MAP
susceptibility, however, with the availability of genome-wide high density SNP maker panels it is now possible to carry out
association studies that have higher precision.
Methodology/Principal Findings: The objective of the current study was to localize genes having an impact on Johne’s
disease susceptibility using the latest bovine genome information and a high density SNP panel (Illumina BovineSNP50
BeadChip) to perform a case/control, genome-wide association analysis. Samples from MAP case and negative controls were
selected from field samples collected in 2007 and 2008 in the province of Lombardy, Italy. Cases were defined as animals
serologically positive for MAP by ELISA. In total 966 samples were genotyped: 483 MAP ELISA positive and 483 ELISA
negative. Samples were selected randomly among those collected from 119 farms which had at least one positive animal.
Conclusion/Significance: The analysis of the genotype data identified several chromosomal regions associated with disease
status: a region on chromosome 12 with high significance (P,561026), while regions on chromosome 9, 11, and 12 had
moderate significance (P,561025). These results provide evidence for genetic loci involved in the humoral response to
MAP. Knowledge of genetic variations related to susceptibility will facilitate the incorporation of this information into
breeding programmes for the improvement of health status.
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Introduction
Mycobacterium avium subspecies paratuberculosis (MAP) causes
paratuberculosis or Johne’s disease in cattle, a chronic granulo-
matous gastroenteritis [1,2]. Johne’s disease occurs worldwide and
is primarily a disease of ruminants, including cattle, sheep, goats,
and farmed deer. However, the disease has a wide host range and
has been reported to occur in non-ruminants species, such as wild
rabbits [3] and their predators, foxes and stoats [4], and in
primates such as mandrills and macaques [5,6].
MAP is responsible for huge economic losses, particularly in
dairy cattle herds [7]. Moreover, several studies have suggested a
link between MAP and Crohn’s disease in man [8–10]. However,
the evidence for a link between Johne’s and Crohn’s diseases
remains controversial and the causal role of MAP has not been
proven [11–13].
In cattle, the disease starts with the slow development of
intestinal lesions in infected animals, a proportion of these animals
become clinically ill after two to six years [14]. Clinical signs of
infection include progressive weight loss, intractable diarrhoea,
decreased milk production and ultimately death [15]. However, in
cattle, Johne’s disease is not treatable and vaccine efficacy it is still
controversial. The prevalence of MAP in farmed animals in
Europe is approximately 20% [16].
The main route of transmission of MAP is the faecal-oral route
[17]; however, it can also be transmitted in the semen of bulls, in
milk to the newborn calf, and in utero across the placenta [2]. In
addition it has also been suggested that MAP can exist within the
tissues of animals for years without causing clinical disease [18,19].
Although the mechanisms that affect the balance between
acquired resistance and progression to clinical disease are
unknown, they may involve maturation of the immune system in
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terms of the various T-cell subsets and the specific tissue
distribution of immune cells. In the early stages of the infection,
MAP infects macrophages in lymphoid tissue in the ileum, where it
inhibits phagosome maturation and induces the recruitment of
inflammatory cells, resulting in granulomatous enteritis. Cattle
typically become infected with MAP as calves; however, clinical
signs of infection do not usually appear before two years of age,
and are most commonly seen after the second or third lactation.
Infected cattle may spread MAP to other animals in the herd
through faecal contamination of the environment, prior to the
appearance of clinical signs [20]. Current Johne’s diagnostic tests
have low sensitivity for detecting the infection in pre-clinical
animals (0.45–0.5) [21], thus testing for MAP may not identify all
infected animals. The sub-clinical stage of MAP infection is
characterized by loss of pro-inflammatory Th1 response and an
increased antibody-mediated Th2 response, however, the mech-
anism by which MAP interacts with the bovine immune system
and suppresses Th1 response remains unclear [22].
Susceptibility to MAP infection has been found to be heritable
[23–26] with heritability estimates ranging from 0.06 to 0.102,
depending the definition of infection, the statistical model used and
the population studied.
Several studies have addressed the identification of genetic loci
associated with MAP susceptibility by testing candidate genes, by
genome-wide linkage or association studies. Polymorphisms in
functional candidate genes, SLC11A1 [27], TLR1, 2 and 4, [28]
and CARD15 [29] have been associated with susceptibility with
MAP infection in cattle. CARD15 has also been associated with
increased the risk of Crohn’s disease in humans [30,31]. Genome
wide linkage analysis provided evidence for a QTL for MAP
susceptibility on Bos taurus chromosome 20 [32] and recently, a
genome wide association study using a high density single
nucleotide polymorphism (SNP) panel (the Illumina BovineSNP50
BeadChip) identified regions on chromosomes 3 and 9 that are
highly significantly associated with the presence of MAP in tissue
and faeces [33]. However, neither of these publications present
evidence for strong functional candidate genes associated with
Johne’s disease in these chromosomal regions.
The current study presents evidence for loci associated with
MAP susceptibility that were identified using a high density SNP
panel (the Illumina BovineSNP50BeadChip whole genome SNP
assay) in a case-control study with a sample size of about 900
Holstein cattle using the presence of antibody against the
bacterium as the definition of susceptibility.
Results
1. Genotype quality assurance and internal population
structure analysis
Following quality control checks, 846 of the 54,001markers
were excluded because of low (,95%) call rate, 6511 markers
were excluded because of low minor allele frequency (MAF)
,0.002 and 294 markers were excluded because they were out of
Hardy-Weinberg equilibrium in controls at a false discovery rate
(FDR ,0.2). With respect to the samples: 26 were removed
because of low call rate (,0.95) and 1 sample was eliminated
because of high autosomal heterozygosity (FDR ,1%). The mean
heterozygosity of the sample was 0.3360.01, while the sample
removed had heterozygosity higher than 0.53, indicating possible
sample contamination. A further 14 samples were removed due to
high IBS (Identity By State). Mean IBS was 0.7360.01, based on
2000 autosomal markers, while the samples removed showed IBS
.0.95. No outliers were identified by Classical Multi Dimension
Scaling (MDS), consequently the final data set that passed the
quality controls and was used in the association analysis contained
46350 Genome wide SNPs and 925 samples.
2. Genome Wide Association Analysis
Genome Wide Analysis identified SNPs with significant
association with MAP antibody response on chromosomes 12, 8,
9, 11, and 27. Genome-wide Manhattan plots displaying the GWA
results with respect to their genomic position, are shown in Figure 1
and details are given in Table 1. All the markers with significant
associations had high call rates, ranging between 0.97 and 0.99,
and MAF ranging between 0.11 and 0.42 (Table 1). Evidence of
population substructure was estimated by the genomic inflation
factor l= 1.15 for a basic chi-square statistics test, and was
completely corrected by the GRAMMAR-CG methodology that
yielded l= 1. The Q-Q plot of the resulting analysis is shown in
Figure 2.
Three moderately significant SNPs were identified on chromo-
some 12 at positions 69663832, 69599639 and 68553182 with p-
values of 1.04 e-06, 1.44 e-06 and 1.50 e-05 and explained 0.48%
0.46% and 0.38% of the phenotypic variance respectively
(Table 1). In addition 2 further SNPs on chromosome 12 at
positions 67342543 and 69808111 showed p-values close to
significance 6.84 e-05 and 7.80 e-05. These SNPs also had high
call rates. The peak defining the region identified by the SNPs on
chromosome 12 is bell shaped indicating a non random
association (Figure 3). A list of the genes located within 1Mb
from the significant SNP identified is provided in Table 2 and their
potential functions are described in Table S1. A graphical
representation of the chromosomal regions associated with MAP
is shown in Figure 3–6. On chromosome 12 (BTA12) two of the
significant SNPs are located in a coding region of the genes
IPI00841680.2 and IPI00824465.3 respectively; both of these
SNPs fall in the intronic region of the gene.
Two further moderately significant SNPs were identified on
chromosomes 9 and 11 (p-value of 1.94 e-05 and 3.93 e-05) at
positions 46362363 and 89695126 explaining 0.34%, 0.33% and
of the variance respectively. A further SNP with high significance
(3.55 e-06) is currently not positioned on the bovine genome
sequence. In addition, 2 SNPs had p-values close to significance:
one on chromosome 8 at position 37257076 and the second on
chromosome 27 at position 45253563, with p-values of 7.02 and
7.55 e-05 respectively (Table 1).
3. Confirmation in smaller cohort
The six SNPs with highest p-values were then tested using the
same test statistics and by simple regression on a smaller cohort of
277 cases and MAP negative control Holstein animals drawn from
the same population used for the main GWA and chosen using the
same criteria as the main cohort. Case-control samples were
randomly chosen to be herd, test day, sex matched, and to reduce
the possibility of animals being related no more than 6 animals
were selected from the same herd. No population substructure was
identified (l= 1). Following correction for multiple testing (n = 6),
five of the six SNPs tested showed significant association with
MAP infection, even in this the smaller cohort (Table 3). These
SNPs were the two most significant SNP on BTA 12, the SNP on 9
and 11 and the un-unmapped SNP identified in the initial study.
Even with the smaller sample size, the SNP on chromosome 11, at
position 89695126, showed a p-value of 8.06 e-05 before
correction for multiple testing, which was as high as the initial
p-value of 6.95e-05 obtained using a larger number of animals.
Following correction for multiple testing, the p-value reduced to
4.80e-04.
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Discussion
Considerable work has been carried out to address the genetic
control of susceptibility and resistance to mycobacterial infections,
including bovine paratuberculosis [23–25,28,29,32–37]. Different
approaches have been used to localise and identify the genes
involved in susceptibility to MAP, including the testing of
candidate genes [27] and QTL mapping using relatively low
density markers [32]. More recently, following the publication of
the bovine genome sequence, a genome wide association study
(GWA) using higher density SNP panels has provided evidence of
a genetic component in Jones’s disease susceptibility [33].
In contrast to human association analysis where, in general,
either small well characterised families, or unrelated individuals
are used, the design of genome wide scans in livestock, based on
field samples with unknown pedigree information, poses a series of
Figure 1. Manhattan plot displaying the results (2log10 of p-value) of the Genome-wide scan using the GRAMMAR-GC method
with respect to their genomic position.
doi:10.1371/journal.pone.0011117.g001
Table 1. List of SNP associated with positive ELISA test to MAP infection indentified by Genome Wide Association study in Holstein
cattle.
SNP name BTA
Position
(bp) N
effB
Q.2 P1df Pc1df
Call
Rate Q.2 P.11 P.12 P.22
Pexact
H-W test
Coding Minor/
major allele
ARS-BFGL-NGS-57278 12 69663832 903 0.157 2.29e-06 1.04e-06 0.97 0.11 722 167 14 0.22 G/A
BTA-95991-no-rs 12 69599639 925 0.154 3.14e-06 1.44e-06 1 0.11 743 167 15 0.12 G/A
BTB-01626215 0 0 909 0.168 7.28e-06 3.55e-06 0.98 0.10 732 177 0 0.0001 G/A
ARS-BFGL-NGS-101584 12 68553182 925 0.134 1.50e-05 7.70e-06 1 0.12 709 198 18 0.37 G/A
ARS-BFGL-NGS-8531 9 46362363 925 0.097 3.59e-05 1.94e-05 1 0.27 496 362 67 0.93 A/G
ARS-BFGL-NGS-17731 11 89695127 923 20.082 6.95e-05 3.93e-05 0.99 0.42 310 445 168 0.73 A/G
ARS-BFGL-NGS-105846 12 67342543 925 0.113 1.17e-04 6.83e-05 1 0.15 659 247 19 0.53 A/G
BTB-02056135 8 37257076 925 20.084 1.19e-04 7.02e-05 1 0.37 356 446 123 0.40 A/C
ARS-BFGL-NGS-37647 27 45253563 925 20.086 1.19e-04 7.55e-05 1 0.11 321 484 120 0.003 A/G
BTB-01470661 12 69808111 900 0.135 1.32e-04 7.80e-05 0.97 0.11 696 203 1 4.75e-05 C/A
SNP name: snp name as in the bovine 50K SNP Chip data.
BTA: Bos Taurus Chromosome.
effB Q.2.: effect of the minor allele (B allele).
P1df: raw p-values before adjustment for Genomic Control.
Pc1df: p-values adjusted for Genomic Control.
Q.2.: frequency of the minor allele allele (B allele).
Pexact H-W test = exact p-value for the test of Hardy-Weinberg estimated in cases and controls together.
doi:10.1371/journal.pone.0011117.t001
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different challenges. There is a high level of relatedness in cattle
populations, especially for dairy cattle, where the effective
population size and number of sires used for artificial insemination
in the recent years is very small [38]. The hidden presence of
closely related animals in the sample set can cause a complex
population structure and an a priori unbalanced distribution of
allele frequencies between cases and controls that is likely to inflate
the rate of false positive associations between the trait and the
markers, and could hide the true associations. Robust methodol-
ogy has been developed to account for genetic background, based
on a polygenic model and which is implemented in the
GRAMMAR-CG approach used in the analysis presented here.
This approach was able to disentangle the cryptic relatedness in
the population by modelling the polygenic relatedness between
pairs of samples [39].
In the present work a genome wide scan using a relatively high
density of markers identified moderately significant associations
between SNPs and MAP serology on chromosomes 9, 11 and 12.
Several SNP markers on chromosome 12 were found to be
significantly associated with MAP within a region of 1 Mb and
formed a distinct peak together with the other SNPs that on their
own fail to reach the threshold for significance (see Figure 1). Two
of the significant SNPs are located in coding regions of two genes
that code for the same protein, the ATP-binding cassette, sub-
family C (CFTR/MRP), member 4 protein (ABCC4) which is a
multi-drug resistance associated protein [40]. The possible role of
this protein in response to Johne’s disease is not known. A study
that used DNA pools created from MAP affected and non affected
animals from two sire families, compared allele frequencies for a
panel of microsatellite markers between the pools and identified a
marker significantly associated to MAP status on BTA12, located
at position 67356645 [32]. This is within 2 Mb from the most
significant SNP reported in the present study, and very close to a
second SNP with a less significant association (p = 6.84 e-05) at
position 67342543. The same QTL study also identified a region
on BTA 20 associated with Johne’s disease [32], however in the
present study there was no evidence for an association with MAP
status on this chromosome.
In the present study a SNP was identified on chromosome 9 at
position 46362363 which was significantly associated with
serologically defined MAP susceptibility. In another study the
neighbouring SNP at position 46423922 was associated with MAP
susceptibility defined by presence of bacteria in tissue of the ileum
in Holstein cattle [33]. One interpretation of these findings may be
that the genetic locus identified on chromosome 9 in these two
studies is generally involved in the process of MAP infection and
control of MAP replication, while the locus on chromosome 12
identified here, that was not identified in the study of Settles et al.
[33], is more specifically involved in antibody response to this
bacterium. This may indicate two or more distinct mechanisms of
resistance that involve different metabolic pathways or different
QTL segregating in different populations.
Two genes are located within 1 Mb, of the significant SNP on
chromosome 9, one of which could be considered a strong
functional candidate identified by comparative annotation:
PRMD1 is a transcription repressor that acts on the beta interferon
gene expression and affects the maturation of B-lymphocytes into
antibody secreting cells. The PRDM1 gene, also known as B
lymphocyte induced maturation protein (Blimp1), has been shown
to play a major role in regulating the functional differentiation of B
and T lymphocytes in humans [41–43], and has also been
implicated in myeloid function [44]. Moreover PRDM1 interacts
with several chromatin-modifying enzymes to induce transcrip-
tional repression at the IFN-beta promoter [45]. Although this
gene was not annotated in cattle, by comparative analysis we were
able to locate the gene on the region of BTA9 where the significant
SNP was located using the similarity with the human ortholog.
Therefore Blimp1 represents a strong candidate to be further
investigated for potential association with Johne’s disease. The
significant SNP located on chromosome 11 in the present study
falls within a QTL region found in another GWA scan for ParaTB
tolerance (Settles, personal communication). This region harbours
several genes: E2F6, PQLC3, C2o50, KCNF1, PDIA6, ATP6V1C2,
NOL10, ODC1, HPCAL1. However, none of these genes are
obvious candidates for Johne’s disease susceptibility based on their
known functions.
The major difficulty with studies using large numbers of tests,
especially using the new high density SNP panels, is setting an
appropriate correction for multiple testing. Traditional methods,
such as Bonferroni correction are likely to be too strict, while
relaxing the correction will increase the false discovery rate.
Therefore independent replication of studies is important to
confirm results. In the present study a smaller cohort of Holstein
drawn from the same population, was used to test the significant
associations identified in the first analysis. This second analysis
confirmed 5 of the 6 moderately significant SNP associations.
Comparison of results across studies of Johne’s disease in cattle
identified only some regions in common. This is not surprising as
the size of a study, the population structure, markers used and
definition of the trait will all contribute to the significance of
different genetic loci. It is therefore interesting to examine regions
reported in other studies that did not pass the threshold for
significance in the present study, to identify if there is any
suggestion of an effect. The definition of an infected animal can be
based either on serology or bacterial culture from tissue or faeces.
Previous studies of heritability estimates were based on serology,
while recent genome wide association study [33] used tissue and
faecal culture of the bacteria as the phenotypes. Differences in the
definition of infected status may explain the different genetic loci
indicated as potentially involved in the susceptibility of Johne’s
disease. In this study MAP negative control animals were selected
based on optimizing exposure to infection, considering animals
Figure 2. Q-Q plot of (GRAMMAR-CG) p-values/against expect-
ed p-values.
doi:10.1371/journal.pone.0011117.g002
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Figure 3. Scatter plots of the chromosomal region in BTA 12 associated with MAP and its corresponding genomic regions (taken
from ENSEMBL).
doi:10.1371/journal.pone.0011117.g003
Table 2. Genomic regions associated with MAP.
SNP BTA Position P-value RefSeq gene (1Mb)
ARS-BFGL-NGS-57278 12 69663832 1.04e-06 GPC6, TYRP2, TGDS, GPR180, SOX21, ABCC4
BTA-95991-no-rs 12 69599639 1.44e-06
ARS-BFGL-NGS-101584 12 68553182 7.70e-06
ARS-BFGL-NGS-105846 12 67342543 6.83e-05
BTB-01470661 12 69808111 7.80e-05
ARS-BFGL-NGS-17731 11 89695127 3.93e-05 E2F6, PQLC3, C2o50, KCNF1, PDIA6, ATP6V1C2,
NOL10, ODC1, HPCAL1
ARS-BFGL-NGS-8531 9 46362363 1.94e-05 PRDM1, PREP
BTB-02056135 8 37257076 7.02e-05 None
ARS-BFGL-NGS-37647 27 45253563 7.55e-05 None
BTB-01626215 0 0 3.55e-06 None
doi:10.1371/journal.pone.0011117.t002
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that shared the same environment for the same period of time
from birth. The ‘‘matched controls’’ are indeed not control
animals in the strict sense, but can be defined as animals from the
same cohort that are currently ‘‘non ELISA reactive’’, compared
to ELISA positive animals. The effect of misclassified animals in
the ‘‘control’’ set would have been a loss of power of the
experimental design, nonetheless, evidence of strong association
with particular SNPs was identified. Using serology data will
identify those loci involved in the immune response to disease,
while the culture of bacteria from tissue may identify genes
involved in persistence of infection at different stages of the disease.
Pinedo et al [27] tested three candidate genes related to the
immune function for an effect on disease: BoIFNG (BTA5), TLR4
(BTA8), SLC11A1/NRAMP1 (BTA2). In the present study a SNP
on BTA8 was close to significance, however it is located more than
70 Mb from the TLR4.
Markers associated with resistance or susceptibility could be
used in breeding strategies to reduce disease incidence. Such
markers could also be the starting point in identifying the genes
and hence the biological pathways, associated with response to
infection with MAP which may be useful in developing diagnostic
tests, or therapeutic approached to control the disease. Confir-
mation of the data presented here will be sought in further
replication studies in independent populations as well as studies in
different breeds.
In summary, the BTA9 association with antibody response to
MAP found in the present study was also seen in a genome-wide
association study for MAP bacterial burden [33]. Significant SNP
on BTA 12 fall within a region identified in an early MAP study
[32]. These two regions merit further investigation, and in
particular the PRDM1 gene on the chromosome 9 is a good
positional and functional candidate.
Figure 4. Scatter plots of the chromosomal region in BTA 8 associated with MAP and its corresponding genomic regions (taken
from ENSEMBL).
doi:10.1371/journal.pone.0011117.g004
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Materials and Methods
1. Animals
Samples were collected from routine Johne’s disease screening
of Holstein cattle carried out between September 2007 and
December 2008 in the province of Lodi in Italy, in area with high
occurrence of Johne’s disease. All samples used in the study
originated from animals routinely tested for MAP and were
obtained in an anonymous form from the State Veterinary
Laboratory within the framework of a local ParaTB eradication
program carried out in collaboration between the breeders
associations and state services. Samples were from animals
belonging to infected herds with high a occurrence of Johne’s
disease, based on the serum antibodies produced in response to
MAP infection using the ID-screenH test (Id.Vet Montpellier,
France). In order to minimize relatedness between animals, as the
presence of closely related individuals would confound the
association analysis, samples were selected from many herds. In
total 2818 samples from Holstein cows were collected from 119
farms, among which, 966 samples were chosen for the study. Of
these samples 483 were MAP antibody positive (cases) and 483
MAP antibody negative (MAP negative controls). All animals were
female, and cases and MAP negative controls were from the same
farm tested on the same day. The ID-screenH test was used to
measure serum antibodies produced in response to M. paratuber-
culosis infection (Id.Vet Montpellier, France). Cases were defined as
animals serologically positive for MAP by ELISA with a sample-
to-positive ratio (S/P) .0.7 and MAP negative controls were
defined as animals showing a sample-to-positive ratio (S/P) ,0.6
as suggested by the supplier. Furthermore, positive animals were
tested twice to confirm the positive result. The Enzyme-linked
immunoassay (ELISA) test is best used as a herd screening test for
M. paratuberculosis and returns a positive result in animals that
progress from an incubation phase to the clinical manifestation of
Johne’s disease. The ELISA test is widely used in heard health
programmes to control the disease.
Figure 5. Scatter plots of the chromosomal region in BTA 9 associated with MAP and its corresponding genomic regions (taken
from ENSEMBL).
doi:10.1371/journal.pone.0011117.g005
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A further set of samples were selected to confirm results, these
were: 277 Holstein cows (140 cases and 137 controls, herd, sex and
test day matched). Clotted blood samples were obtained following
the recovery of serum for MAP ELISA testing. DNA was extracted
from the clotted blood as follows: the clot was washed with the EL
buffer (NH4Cl 0.15M, KHCO3 10 mM, EDTA 0.5) and then the
samples were incubated with KL buffer (SDS 1%, TRIS 1M,
EDTA 0.5M, NaCl 5M) and proteinase K at 60uC for three hours.
DNA was then extracted using a standard phenol-chloroform
protocol, followed by an ethanol precipitation.
The 966 samples, plus 9 duplicated samples as technical
replicates, were genotyped by GeneSeek Inc (Nebraska, USA)
using the Illumina BovineSNP50 BeadChip which contains 54001
SNPs with an average spacing of 51.5 kb and a median spacing of
37.3 kb, based on the BTAU4.0 assembly (ftp://ftp.hgsc.bcm.tmc.
edu/pub/data/Btaurus/). Genotypes were assigned using BEAD-
STUDIO (Illumina, San Diego) software.
2. Genotype quality assurance and internal population
structure analysis
Genotype quality assurance was performed within the R
statistical environment using the GenABEL package as imple-
mented with the ‘‘check.marker’’ function [46]. Data was quality
controlled for marker call rate, minor allele frequency and Hardy
Weinburg Equilibrium (HWE): markers missing 5% of data, or
with MAF of less than 2% were removed as were markers that
were significantly out of HWE. Genotyping efficiency for samples
was also verified and samples with more than 5% missing data
were removed. The duplicated samples showed 99.9% concor-
dance of genotypes calls.
Figure 6. Scatter plots of the chromosomal region in BTA 11 associated with MAP and its corresponding genomic regions (taken
from ENSEMBL).
doi:10.1371/journal.pone.0011117.g006
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Classical Multi Dimension Scaling (MDS) was used to explore
population substructure and to verify the genetic homogeneity of
the sample set prior to analysis. Pair wise identities by state (IBS)
were calculated for all 966 samples based on autosomal SNPs
using identity matrices as implemented in the GenABEL library
[46].
3. Statistical analysis
Genome-wide association analysis was performed using the
GenABEL package [46] in R using a three step GRAMMAR-CG
approach, (Genome wide Association using Mixed Model and
Regression - Genomic Control), with the extension of using the
genomic kinship matrix estimated through genomic marker data,
instead of the pedigree [39,47]. First an additive polygenic model
was used to obtain individual environmental residuals using the
polygenic function of the GenABEL library to disentangle the
cryptic population structure caused by the presence of closely
related animals in the sample set [39]. To account for relatedness,
the variance/covariance matrix was estimated from the genomic
kinship matrix, as pedigree information was not available. The
relationship matrix used in the analysis was estimated using
genomic data with the ‘‘ibs’’ (option weight = ‘‘freq’’) function of
GenABEL. Secondly, association was tested using a simple least
squares method on the residuals, corrected for cryptic relatedness,
familiar correlation, and independent of pedigree structure.
Thirdly, the Genomic Control (GC) approach was used to correct
for conservativeness of the GRAMMAR test, based on the
estimation of the lambda factor, which is the median of all
genome-wide observed test statistics divided by the expected
median of the test statistic under the null hypothesis of no
association, assuming that the number of true associations is very
small compared to the number of tests that are actually performed.
Cases were defined as animals serologically positive for MAP by
ELISA with a sample-to-positive ratio (S/P) .0.7 and MAP
negative controls were defined as animals showing a sample-to-
positive ratio (S/P) ,0.6. Cases were set to 1 and MAP negative
controls to 0. Uncorrected p-values ,561027 were accepted to
represent very strong proof of genome-wide association, while p-
values between 561027 and 561025 were considered as
moderately significant associations.
SNP effects were then estimated using the formula V = 2pqa2
where p and q are the frequencies of the minor and major alleles
and a is the allelic substitution effect [48]. Further to the initial
genome-wide association study (GWAS) a confirmatory associa-
tion study (CMAS) was carried out, using a smaller randomly
selected sub-set of animals belonging to the same initial cohort of
Holstein samples used in the initial the GWA. The analysis of
these data followed the same statistical approach as described
above. The threshold for confirmation of significant results in the
smaller Holstein cohort was set at a p-value of less than 0.05
divided by the actual number of SNPs tested (n = 6).
SNP location and gene names were based on the Btau_4.0,
assembly released on 4 October 2009 (http://www.ensembl.org).
All analyses were carried out within the R statistical environment
(http://www.r-project.org).
Supporting Information
Table S1 Functional description of the genes present in the
genomic regions associated with MAP within 1MB from the SNP.
Found at: doi:10.1371/journal.pone.0011117.s001 (0.06 MB
DOC)
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